BMI View: While Norway's reliance on pharmaceutical imports highlights opportunities for drugmakers
looking to export medicines into the country, we note that the Norwegian pharmaceutical market has
displayed very slow or no growth in recent years, which may ultimatel ..."
BMI View: While Norway's pharmaceutical market is small, BMI believes the country's high public
expenditure on health, stringent regulatory climate (recognised by the US and the EU) and stable and
transparent business environment - similar to that of its regional neig ..."
OVERVIEW OF THE PHARMACEUTICAL MARKET IN NORWAY
The macroenvironment for the Norwegian pharmaceutical industry is improving. Politically, the centre-left coalition is expected to hold together at least until the general election in September 2013, but the risk of the coalition ..."